Skip to main content

Table 1 Characteristics of all patients

From: Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma

 

Patients with RILD

Patients without RILD

Variables

N = 13

N = 23

Gender

 Male

11

19

 Female

2

4

Median age at reirradiation

64

71

(range, 32 to 77)

(range, 33 to 89)

TNM stage (AJCC 7th edition)

 T1N0M0

2

4

 T2N0M0

1

7

 T3N0M0

5

9

 T4N1M0

1

0

 T3N0M1

4

3

Previous local treatment

 Surgery

1

2

 TAE/TACE

7

12

 RFA/Cryo

2

5

Category of previous hepatitis

 Hepatitis B infection

6

10

 Hepatitis C infection

2

6

 non-HBV and non-HCV induced

5

7

 CTP scores before the 2nd RT

6.3 ± 1.1

5.2 ± 0.5

 Interval between 2 courses (months) abutting score for two PTV

8.1 ± 8.1

12.6 ± 12.2

 0

4

5

 1

2

9

 2

7

9

1st RT parameters

 Mean prescribed dose (EQD2, Gy)

49.5 ± 8.2

52.5 ± 5.7

 Mean CTV (cm3)

392.9 ± 407.0

345.2 ± 565.0

 Mean PTV (cm3)

257.9 ± 207.8

314.4 ± 480.7

 Mean normal liver dose (EQD2, Gy)

20.8 ± 11.3

20.1 ± 8.2

 Mean normal liver volume (cm3)

1255.5 ± 569.4

926.5 ± 242.4

2nd RT parameters

 Mean prescribed dose (EQD2, Gy)

32.9 ± 14.5

40.6 ± 12.8

 Mean CTV (cm3)

139.1 ± 150.2

211.3 ± 343.1

 Mean PTV (cm3)

257.9 ± 207.8

314.4 ± 480.7

 Mean normal liver dose (EQD2, Gy)

12.3 ± 6.6

10.2 ± 5.5

 Mean normal liver volume (cm3)

1173.4 ± 622.2

992.5 ± 196.1

 Mean cumulative prescribed dose (EQD2, Gy)

80.9 ± 17.8

94.4 ± 13.9

 Mean cumulative normal liver dose (EQD2, Gy)

32.5 ± 15.1

30.5 ± 9.6

  1. Abbreviation: RILD radiation-induced liver disease, TNM stage was evaluated before reirradiation; TAE transarterial embolization, TACE transarterial chemo-embolization, RFA radiofrequency ablation, Cryo cryotherapy, RT radiotherapy, CTV clinical tumor volume, PTV planning target volume, EQD2 biologically equivalent doses calculated in 2Gy
  2. Note: abutting score: if reirradiation applied to a PTV separated from the previous PTV because the tumors were located at different segments, this situation was defined as out-field reirradiation (score = 0). For patients receiving reirradiation at the same or adjacent segment, the 2nd PTVs might be partially included in the previous PTV (score 1), or completely included (score 2)